|
FY2025
12 months to Dec 27, 2025
|
FY2024
12 months to Dec 28, 2024
|
FY2023
12 months to Dec 30, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Jan 1, 2022
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES: | |||||
| Net loss | |||||
| Net income (loss) | |||||
| Net loss from continuing operations | |||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Change in reserve for uncollectible accounts | |||||
| Gain on reversal of contingent liabilities | |||||
| Impairment charges | |||||
| Gain on sale of GeoTraq | |||||
| Accretion of note receivable discount | |||||
| Accretion of seller note discount | |||||
| Stock based compensation expense | |||||
| Bad debt expense | |||||
| Common stock issued for settlement agreement | |||||
| Noncash expense for stock issuances | |||||
| Related party notes issued for shared services | |||||
| Write off of VM7 note receivable | |||||
| Write off of SPYR note receivable | |||||
| Unrealized loss on cryptocurrency assets | |||||
| Realized loss on digital assets | |||||
| Unrealized loss on marketable securities | |||||
| Amortization of right-of-use assets | |||||
| Unrealized gain on digital assets | |||||
| Change in deferred income taxes | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Digital assets receivable | |||||
| Prepaid expenses | |||||
| Other current assets | |||||
| Accounts payable and accrued expenses | |||||
| Digital assets payable | |||||
| Operating cash flows provided by discontinued operations | |||||
| Net cash (used in) provided by operating activities | |||||
| INVESTING ACTIVITIES: | |||||
| Purchases of property and equipment | |||||
| Cash acquired in ALT5 Subsidiary acquisition | |||||
| Cash acquired in Mswipe acquisition | |||||
| Cryptocurrency assets purchased | |||||
| Cryptocurrency assets redeemed | |||||
| Investing cash flows used in discontinued operations | |||||
| Net cash (used in) provided by investing activities | |||||
| FINANCING ACTIVITIES: | |||||
| Proceeds from issuance of notes payable | |||||
| Payments on related party notes payable | |||||
| Proceeds from the issuance of related party note payable | |||||
| Proceeds from equity financings, net | |||||
| Warrants exercised | |||||
| Payments on notes payable | |||||
| Proceeds from equity financing | |||||
| Payments of placement fees | |||||
| Financing cash flows used in discontinued operations | |||||
| Net cash provided by financing activities | |||||
| Effect of changes in exchange rate on cash and cash equivalents | |||||
| INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | |||||
| Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation | |||||
| CASH AND CASH EQUIVALENTS, beginning of period | |||||
| LESS CASH OF DISCONTINUED OPERATIONS, end of period | |||||
| CASH AND CASH EQUIVALENTS OF CONTINUING OPERATIONS, end of period | |||||
| Supplemental cash flow disclosures: | |||||
| Noncash recognition of new leases | |||||
| Interest paid | |||||
| Income tax refunds received, net | |||||
| Noncash financing and investing activities: | |||||
| Common stock issued for prefunded warrants | |||||
| Common stock issued for the acquisition of Mswipe | |||||
| Common stock warrants issued for the acquisition of Mswipe | |||||
| Alyea common stock issued for the acquisition of Mswipe | |||||
| Convertible preferred Series Q shares converted to common stock | |||||
| Convertible preferred Series M shares converted to common stock | |||||
| Stock issued for the acquisition of Alt5 Subsidiary | |||||
| Stock issued for the acquisition of Alt5 Subsidiary | |||||
| Common stock issued for consulting services | |||||
| Common stock issued for liability obligations | |||||
| Common stock issued for interest obligations | |||||
| Common stock issued for property and equipment | |||||
| Preferred stock issued for intangible assets | |||||
| Total stock issued for the acquisition of Alt5 Subsidiary | |||||
| Notes payable converted to common stock | |||||
Loading...